All specimens and clinical data were obtained with either informed written consent or a formal waiver of consent under protocols approved by the Research Ethics Board of the BC Cancer Agency and the University of British Columbia.
Citation: Milne K, Köbel M, Kalloger SE, Barnes RO, Gao D, Gilks CB, et al. (2013) Correction: Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors. PLoS ONE 8(7): 10.1371/annotation/976c923b-d991-4a33-b060-cdd8770bdf5d. https://doi.org/10.1371/annotation/976c923b-d991-4a33-b060-cdd8770bdf5d
Published: July 23, 2013
Copyright: © 2013 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests: No competing interests declared.